The telehealth space was hot in 2020 and Conversion Labs (CVLB) is playing perfectly into this trend. The company is quickly ramping up some new direct-to-consumer subscription services while building a telehealth platform for future products. The stock is appealing here after a notable firm made a bullish case on the stock.